Decreased paraoxonase 1 (PON1) lactonase activity in hemodialyzed and renal transplanted patients. A novel cardiovascular biomarker in end-stage renal disease

Ferenc Sztanek1⇓ Ildikó Seres1 Mariann Harangi1 Lajos Lőcsey2 János Padra1 György J.R. Paragh3 László Asztalos2 and György Paragh1

首页> 外文期刊>Nephrology Dialysis Transplantation >Decreased paraoxonase 1 (PON1) lactonase activity in hemodialyzed and renal transplanted patients. A novel cardiovascular biomarker in end-stage renal disease

【24h】

Decreased paraoxonase 1 (PON1) lactonase activity in hemodialyzed and renal transplanted patients. A novel cardiovascular biomarker in end-stage renal disease

机译：血液透析和肾移植患者中对氧磷酶1（PON1）内酯酶活性降低。终末期肾脏疾病中的新型心血管生物标志物

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Nephrology Dialysis Transplantation》 |2012年第7期|p.2866-2872|共7页
作者
Ferenc Sztanek1⇓ Ildikó Seres1 Mariann Harangi1 Lajos Lőcsey2 János Padra1 György J.R. Paragh3 László Asztalos2 and György Paragh1;
展开▼
作者单位

1First Department of Medicine, Medical and Health Science Center, University of Debrecen, Debrecen, Hungary 2Institute of Surgery, Medical and Health Science Center, University of Debrecen, Debrecen, Hungary 3Louis A. Weiss Memorial Hospital, Chicago, IL, USA;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类
关键词

相似文献

外文文献
中文文献
专利

1. Decreased paraoxonase 1 (PON1) lactonase activity in hemodialyzed and renal transplanted patients. A novel cardiovascular biomarker in end-stage renal disease [J] . SztanekF., SeresI., HarangiM., Nephrology, dialysis, transplantation: official publication of the European Dialysis and Transplant Association - European Renal Association . 2012,第7期

机译：血液透析和肾移植患者中对氧磷酶1（PON1）内酯酶活性降低。终末期肾脏疾病中的新型心血管生物标志物
2. Serum paraoxonase 1 (PON1) lactonase activity is lower in end-stage renal disease patients than in healthy control subjects and increases after hemodialysis. [J] . Gugliucci A, Kinugasa E, Kotani K, Clinical chemistry and laboratory medicine: CCLM . 2011,第1期

机译：终末期肾病患者的血清对氧磷酶1（PON1）内酯酶活性低于健康对照组，血液透析后升高。
3. Effect of renal transplantation on biomarkers of inflammation and oxidative stress in end-stage renal disease patients. [J] . Simmons EM, Langone A, Sezer MT, Transplantation: Official Journal of the Transplantation Society . 2005,第8期

机译：肾移植对终末期肾脏疾病患者炎症和氧化应激生物标志物的影响。
4. Non-Traditional Cardiovascular Disease Risk Factors and Arterial Inflammatory Response in End-Stage Renal Disease [C] . Tomris Ozben North Atlantic Treaty Organization Advanced Study Institute. meeting . 2003

机译：非传统心血管疾病危险因素及末期肾病中的动脉炎症反应
5. Predictors of health care utilization among end-stage renal disease patients. [D] . Gomes, Cynthia J. 2001

机译：终末期肾病患者中医疗保健利用的预测指标。
6. Serum Cystatin C Is a Determinant of Paraoxonase Activity in Hemodialyzed and Renal Transplanted Patients [O] . Éva Varga, Ildikó Seres, Mariann Harangi, 2009

机译：血清胱抑素C是血液透析和肾脏移植患者对氧磷酶活性的决定因素。
7. Decreased paraoxonase 1 (PON1) lactonase activity in hemodialyzed and renal transplanted patients. A novel cardiovascular biomarker in end-stage renal disease [O] . Ferenc Sztanek, Ildikó Seres, Mariann Harangi, 2012

机译：血液透析和肾移植患者中的副氧酶1（PON1）乳酸酶活性降低。一种新型心血管生物标志物在末期肾病
8. End-Stage Renal Disease: Characteristics of Kidney Transplant Recipients, Frequency of Transplant Failures, and Cost to Medicare [R] . 2007

机译：终末期肾病：肾移植受者的特征，移植失败的频率和医疗保险的成本

Decreased paraoxonase 1 (PON1) lactonase activity in hemodialyzed and renal transplanted patients. A novel cardiovascular biomarker in end-stage renal disease

著录项

相似文献

相关主题

期刊订阅